Summary In this study, label-free-based quantitative subcellular proteomics integrated with network analysis highlighted several candidate genes including P4HB, ITGB1, CD36, and ACTN1 that may be involved in osteoporosis. All of them are predicted as significant membrane proteins with high confidence and enriched in bone-related biological process. The results were further verified in transcriptomic and genomic levels. Introduction Osteoporosis is a metabolic bone disease mainly characterized by low bone mineral density (BMD). As the precursors of osteoclasts, peripheral blood monocytes (PBMs) are supported to be important candidates for identifying genes related to osteoporosis. We performed subcellular proteomics study to identify significant membrane proteins that involved in osteoporosis. Methods To investigate the association between monocytes, membrane proteins, and osteoporosis, we performed labelfree quantitative subcellular proteomics in 59 male subjects with discordant BMD levels, with 30 high vs. 29 low BMD subjects. Subsequently, we performed integrated gene enrichment analysis, functional annotation, and pathway and network analysis based on multiple bioinformatics tools. Results A total of 1070 membrane proteins were identified and quantified. By comparing the proteins' expression level, we found 36 proteins that were differentially expressed between high and low BMD groups. Protein localization prediction supported the notion that the differentially expressed proteins, P4HB (p = 0.0021), CD36 (p = 0.0104), ACTN1 (p = 0.0381), and ITGB1 (p = 0.0385), are significant membrane proteins. Functional annotation and pathway and network analysis highlighted that P4HB, ITGB1, CD36, and ACTN1 are enriched in osteoporosis-related pathways and terms including BECM-receptor interaction,^Bcalcium ion binding,B leukocyte transendothelial migration,^and Breduction of cytosolic calcium levels.^Results from transcriptomic and genomic levels provided additional supporting evidences. Conclusion Our study strongly supports the significance of the genes P4HB, ITGB1, CD36, and ACTN1 to the etiology of osteoporosis risk.
Introduction
Osteoporosis, a global public health problem with high heritability, is mainly characterized by low bone mineral density (BMD) [1] . Osteoporosis has become one of the most serious public health problems around the world, leading to millions of fractures annually [1, 2] . Among fractures at various skeletal sites, hip fracture is the most severe risk owing to its high prevalence, high morbidity and mortality, and excessive therapeutic cost [3, 4] . Monocytes are bone marrow-derived circulating leukocytes that can further differentiate into various cell types like macrophages and dendritic cells [5] . Peripheral blood monocytes constitute 5-10% of human leukocytes which can be easily isolated and purified from blood sample from individual subject [6] . In this study, we used the classical peripheral blood monocyte (PBM) subset (CD14 ++ CD16 − ) for our proteomics study. It is difficult (or nearly impossible) to collect fresh and sufficient osteoclasts from bone tissues in humans for an in vivo study like the present one, so we chose PBMs for osteoporosis study due to availability in large quantities and their important roles in osteoclastogenesis. As the sole source of osteoclasts in adult, human PBMs serve as precursors of osteoclasts and produce cytokines important for osteoclast differentiation, activation, and apoptosis and may also act as one of the most important target cells for sex hormones in bone metabolism [7, 8] . Therefore, PBMs are a major class of cells that are functionally relevant to the pathogenesis of osteoporosis, and they have been successfully used for bonerelated etiology studies [8, 9] .
Based on biochemical methods for isolation of subcellular components, integrated with sensitive LC-nano-ESI-MSE (liquid chromatograph-nano-electrospray ionization-mass spectrometry)-based quantitative proteomic analysis, subcellular proteome profiling can enhance coverage for each specific subcellular component while also provide more accurate localization of biological function for target proteins. Membrane proteins play significant roles in different human physiological processes including acting as signal receptors, enzymes, transport units, and cell adhesion molecules. Membrane proteins are directly or indirectly related to multiple human diseases including osteoporosis [10] [11] [12] . Missense mutations that disrupt membrane protein assembly often lead to diseases [13] . Transmembrane domains play central roles in disease-related pathways [14] .
Network analysis can identify interactive correlation and topology between different proteins. Pathways/modules generated by network analysis may reflect biological processes more comprehensively and objectively than single protein/gene analysis [15] . Based on the utilization of functional information and topological information, there are quite a few approaches to perform gene enrichment analysis, pathway analysis, functional cluster analysis, and network reconstruction analysis [16] . For instance, DAVID (Database for Annotation, Visualization, and Integrated Discovery) is a popular knowledgebase composed of multiple online tools which can provide abundant functional information from multiple databases for a list of genes. However, the topological features generated from DAVID may be quite limited [16, 17] . In contrast, as a frequently used platform for network analyses, the STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) database engine can provide more topological information [16, 18] , including protein-protein interaction. Furthermore, Cytoscape, an open source software project for data integration, network analysis, and visualization [19] , is a powerful tool with hundreds of comprehensive and up-to-date applications which can provide multiple functions of network analyses.
Based on label-free quantitative proteomics and integrative network analysis, our purpose in this study is to identify significant membrane proteins and the corresponding pathways/ terms involved in osteoporosis. In order to gain additional evidences, we performed validation studies in multi-omics levels including proteomics, transcriptomics, and genomics levels.
Materials and methods

Human subjects
Our study was approved by the Institutional Review Boards of University of Missouri Kansas City and Tulane University. All subjects signed consent forms before being enrolled. A total of 59 unrelated Caucasian men from Kansas City, Missouri, and its surrounding areas were enrolled in the study. They were composed of 29 subjects with low hip BMD and 30 subjects with high hip BMD (Z-score mean ± standard deviation, −1.2 ± 0.4 vs. 1.6 ± 0.6, respectively) ( Table 1) , corresponding to the top 6% (low BMD) vs. 16% (high BMD) of BMD distribution in Caucasian population [20] . The hip BMD (g/cm 2 ) (which is the combined value of three regions including femoral neck, trochanter, and interchochanter) were measured using a Hologic 4500 W dual energy X-ray bone densitometer for each subject as we routinely do [9] .
In order to minimize the influence of environmental factors that may affect bone metabolism, several chronic diseases and conditions were excluded. Detailed exclusion criteria have been described in previous studies [21] and mainly include chronic disorders of vital organs, autoimmune-related diseases, metabolic diseases, skeletal diseases, hematopoietic diseases, lymphoreticular diseases, and other diseases or any treatment that would affect gene/protein expression.
Peripheral blood monocyte isolation
One hundred twenty milliliters peripheral blood was drawn from each subject by a certificated phlebotomist. EDTA was used as anticoagulant, and fresh blood samples were processed immediately for PBM isolation following phlebotomy by experienced technicians. The PBMCs were isolated from whole blood using density gradient centrifugation with Histopaque-1077 (Sigma-Aldrich, Cat. No.10771). PBM isolation was performed with the Monocyte Isolation Kit II (Miltenyi Biotec, Cat. No. 130-091-153) following the manufacturer's recommendation. Flow cytometry analyses showed that the purity of isolated monocyte samples was more than 90%.
Subcellular proteome extraction
Utilizing different solubilities of certain subcellular compartments in the four selected reagents, four subcellular compositions (cytosolic fraction, membrane/organelle protein fraction, nucleic protein fraction, cytoskeletal fraction) were extracted from collected PBMs using the ProteoExtract® Subcellular Proteome Extraction Kit (Emd Millipore, Cat. NO. 539790) (S-PEK) following the manufacturer's instruction.
Proteome-wide protein expression profiling
PBM membrane proteome studies were profiled using a method of 2D-nanoLC-ESI-MS/MSE, through nanoAcquity ultra performance liquid chromatography coupled with Synapt high-definition mass spectrometry (HDMS) (Waters Corporation). The MassLynx 4.1 software (Waters) monitors proteome data acquisition. The protein digests (~500 ng) were injected into a 300um × 50 mm XBridge PST C18 NanoEase Column (Waters) and separated by solvent A (water with 0.1% FA) and solvent B (acetonitrile with 0.1% FA) at a flow rate of 0.3 μl/min using a gradient of 2 h as follows: 3% B initial, 10% B at 1.0 min, 30% B at 75 min, 40% B at 90 min, 95% B at 91 min, 95% B at 95 min, and 3% B at 96 min, equilibrate thereafter till 120 min. The eluate was analyzed by HDMS under positive ion V-mode. The following parameters were set for data acquisition: collision energy: 5 V for MS and ramp 15-40 V for MSE; scan time, 0.6 s per scan. The HDMS machine was calibrated daily to ensure high accuracy (2.0 ppm for lock mass of m/z 785.8426). LC-nano-ESI-MSE original datasets were acquired from each PBM proteome digest sample. Then, the acquired MSE data were processed with the ProteinLynx Global Server (PLGS) v2.4 (Waters) using the appropriate parameters recommended by Waters Corporation. Specific information regarding database searching and protein quantification based on PLGS can be found in our previous publications [21, 22] . Protein identification was achieved by searching an integrated human protein database including 153,078 protein entries from UniProt database, NCBI Reference Sequence Database (RefSeq database), Ensembl genome database, the Vertebrate Genome Annotation (VEGA) database, and H-Invitational (H-INV) database. Total ion counts of the top three matched peptides were used to quantify each protein. We added 100 femtomols of ADH1 in each prepared sample as internal references (recommended by Waters Corporation). By comparing the ion counts of each protein with ADH1, protein quantification level was exported in femtomol and nanogram.
Protein differential expression analyses
In order to detect the significant differentially expressed proteins (DEPs), the quantitative proteomics dataset was first normalized by the housekeeping protein beta actin. Then, protein expression values were adjusted using a linear regression model by weight and height to minimize their effects of individual differences between subjects. Then, using the normalized and adjusted data, we performed Student's t test in subjects with low vs. high BMD. A p value less than 0.05 was set as the nominal cut off for statistical significance.
Functional annotation and gene enrichment analysis
The DAVID knowledgebase agglomerated tens of millions of gene/protein identifiers from a variety of public genomic resources; these identifiers improve cross-reference capability, particularly across NCBI and UniProt systems. More than 40 publicly available functional annotation sources have been comprehensively integrated and centralized by the DAVID gene clusters [17] . In order to maximize the coverage of important biological information, we imported all the unique gene symbols into this online tool for functional annotation and enrichment analysis. Comprehensive functional information for all of these genes enriched in specific terms was obtained. The results were classified as Bfunctional annotation clustering,^Bfunctional annotation chart,^and Bfunctional annotation table.^We selected several terms/pathways to report based on three reasons as follow: firstly, all of them have significant p value (p < 0.05). Secondly, all of them are supported to be related with bone metabolism by extensive publications. Thirdly, each of them should contain at least one significant gene.
Pathway and network analysis and visualization based on DEPs
In order to observe the interactions between DEPs from subcellular proteomics profiling, 36 DEPs were imported into the online tool STRING for pathway and protein-protein interaction analysis. It is well-known that the interactions between proteins represent a crucial component for modern biology including proteomics studies. User-friendly and comprehensive, the STRING knowledge database has been designed to assemble, evaluate, and disseminate protein-protein association information [18] . In addition, all DEPs were imported into Cytoscape for network construction and visualization. ClueGO in conjunction with CluePedia, two easy-to-use applications based on Cytoscape_v3.2.0, greatly improved biological interpretation of large lists of genes, consequently providing a comprehensive view from different perspectives [23, 24] . The exported network gives a visualized summary of the interaction between protein and pathway/terms.
Validation studies: transcriptomics and genomics levels
To gain additional support for the candidate genes identified in our proteomics study, we assessed associations with BMD at different levels of previously published cohorts including RNA expression datasets and genome-wide association study (GWAS) dataset. At the transcriptomic level, four independent datasets were used. Cohort I contains 19 Caucasian females, including 10 high and 9 low hip BMD subjects (Affymetrix Human Genome U133A Array; GDS1287) [8] . Cohort II contains 26 Chinese females including 14 high and 12 low hip BMD subjects (Affymetrix Human Genome U133 Plus 2.0 Array; GSE7158) [25] . Cohort III contains 73 Caucasian females including 42 high and 31 low hip BMD subjects (Affymetrix 1.0 ST arrays; GSE56814) [26] . Cohort IV contains 80 Caucasian females, including 40 high and 40 low hip BMD subjects (Affymetrix Human Genome U133A Array; GSE56815) [27] . Genes with p values less than 0.05 are purported to be DEPs between high and low BMD groups and thus are significantly associated with osteoporosis. A previous paper published by our group gave a specific introduction to these datasets [26] . At the genomic level, a previously released whole-genome sequencing, whole-exome sequencing dataset from the Genetic Factors for Osteoporosis (GEFOS) Consortium (http://www.gefos.org/) was used for validation studies [28] . The meta-analysis dataset contains 9 GWASs, a total of 32,965 subjects and approximately 10 million SNPs. In this study, we performed a gene-based integrative analysis to evaluate the association between gene and hip BMD in multi-omics levels. Firstly, we determine gene-phenotype association scores separately for single omics data. For gene g, we computed q k g (k = 1,…, D, where D is the number of omics data) to capture the relationship between gene and phenotype in different omics levels. If several datasets were used at a single omics level (kth omics), we will first integrate the information from different datasets for each kind of omics data by a meta-analysis-based approach [29] : ) across D omics data into an overall score (S g_meta ):
S g_meta has a chi-squared distribution with 2D degrees of freedom, if there is no association between phenotype and any omics data for gene g. Finally, the p value for the overall score S g_meta was adjusted using false discovery rate (FDR) in order to correct for multiple hypothesis testing [30] . Note that if there are more than one signals (e.g., probes or SNPs) for gene g in one cohort data, the signal with most significant association with the phenotype will be chosen as a representation for gene g.
Results
Proteomics profiling
In this study, based on monocytes membrane component, among a total of 59 subjects, 1070 proteins corresponding to 516 unique genes were detected in five or more subjects by LC-nano-ESI-MSE, which were used for further analyses [21] . Among the 1070 proteins, 97.76% proteins were identified in both high and low BMD groups. Furthermore, a global normalization method was applied for data quality control in order to minimize the variability due to sample preparation or equipment conditions. We applied log2 transformation of our data for further analyses.
Identification of differentially expressed proteins
Based on adjusted protein expression value, we applied Student's t test to detect DEPs in low and high BMD groups. A total of 36 unique proteins were identified as DEPs (at a nominal significance level of p < 0.05). Among these 36 proteins, 11 proteins are upregulated and 25 proteins are downregulated in H BMD group (Table 2) .
Gene enrichment analysis and functional annotation
Corresponding to the total of 1070 proteins, 516 unique gene symbols were imported into the DAVID online tool for functional annotation and gene enrichment analysis. A total of 1405 terms in 13 categories were generated. As expected, most genes identified in this study were enriched in membrane related terms (Table 3) . For the biological process and molecular function terms, with an integrated consideration of statistical results and physiological features, we highlighted several significant terms closely related to osteogenesis, bone metabolism, and skeletal physiology, such as Bleukocyte transendothelial migration,^Bcalcium ion binding,^and BEF-hand type (calcium-binding motifs).^Individually, the DEPs included in selected terms were given (Table 4) .
Pathway analysis, network reconstruction, and visualization
A total of 36 differentially expressed genes were imported into the STRING online tool for pathway and protein-protein interaction analysis. By evaluating the interaction between each differentially expressed gene, a visualized network was generated. We discarded those without interaction with other genes (Fig. 1) . We highlighted several significant membrane genes such as CD36, ITGB1, ACTNI, and P4HB in this gene set (marked in Fig. 2 with red rectangles). All the DEPs were significantly enriched in 15 pathways (FDR < 0.05) based on the KEGG pathway database (Supplementary Table 1 ). In particular, those four genes play multiple and significant roles in bone-related pathways including the BECM (extracellular matrix) receptor interaction pathway^and the Bleukocyte transendothelial migration pathway.^Subsequently, network construction and visualization based on Cytoscape showed associations between DEPs and biological pathways/ modules (Fig. 2) . Specifically, they play central roles in numerous pathways/modules including response to elevated platelet cytosolic Ca 2+ , the adherens junction pathway and the leukocyte transendothelial migration pathway which are thought to be related to osteogenesis, bone formation, and resorption. Integrative pathway and network analysis provided a comprehensive and intuitively visualized report of the relationship between DEPs and biological pathways/terms, which allowed us to better understand the biological function of the DEPs.
Evidence from validation studies
To gain additional evidence for the candidate genes identified in our proteomics study, we performed validation studies at both transcriptomic and genomic levels, trying to seek validation across omics levels for those genes that are significant across sex. In RNA expression datasets, we found that CD36 is differentially expressed in the cohort I (p = 0.0158) and cohort II (p = 0.027). ACTN1 is differentially expressed in cohort I (p = 1.48E-05) and cohort IV (p = 0.0001). In the meta-analysis GWAS dataset, the most significant SNPs, rs144803881 (p = 0.0348), rs41272372 (p = 0.0121), rs150197367 (p = 0.0089), and rs4541004 (p = 0.0053) in genes P4HB, CD36, ITGB1, and ACTN1 are thought to be involved in osteoporosis (Supplementary Tables 2) . Metaanalysis in multi-omics levels also indicates that the above four genes are significantly associated with osteoporosis. Since the proteomics study is based on male subjects, the validation studies contain subjects from both genders, we further verified that the above four genes are all located in euchromosome and have cross-sex effect in both genders. In conclusion, evidence from both transcriptomic and genomic levels further supported the contribution of these four genes to osteoporosis.
Discussion
Subcellular proteome profiling can enhance the coverage for each specific subcellular component, while also provide more accurate localization of biological function for target proteins. However, presenting an exact map of subcellular distribution of all proteins under different conditions is challenging, because protein subcellular localization is dynamic, without strict limitations or boundaries [31] . In particular, membrane or transmembrane proteins are often in extremely low abundance but play multiple and significant roles as signal receptors, enzymes, transport proteins, biomarkers, and cell adhesion molecules [32] . In this study, by using an efficient and reliable subcellular extraction kit in conjunction with high sensitivity and resolution LC-MS instruments, we performed comprehensive proteomics profiling in human monocyte membrane. In the cellular component analysis, as expected, most genes were enriched in membrane related terms (Table 3 and Fig. 2 ) which indicates that most of the corresponding proteins identified in our study are membrane proteins. Subsequently, integrated gene enrichment analysis, functional annotation, and pathway and network analysis based on multiple bioinformatics tools highlighted several significant membrane genes involved in osteoporosis including P4HB, ITGB1, ACTN1, and CD36. With an integrated consideration of statistical results and physiological features, we selected these four genes to report based on the following four reasons: firstly, these four genes are identified as differentially expressed genes, all of them have significant p value: P4HB (p = 0.0021), CD36 (p = 0.0104), ITGB1 (p = 0.0385), ACTN1 (p = 0.0381) ( Table 2 ). Secondly, this study is a subcellular proteomics study based on membrane component of human PBMs, and these four genes are supported as significant membrane genes in cellular component analysis (Table 3) . Thirdly, pathway and network analysis suggested that these four genes are involved in osteoporosis related terms and pathways such as Bleukocyte transendothelial migration,Ô steoporos Int (2017) 28:3033-3042 Bcalcium ion binding,^and BECM-receptor interaction (  Table 4 and Fig. 2) . Fourthly, validation study at multiomics levels indicated that these four genes are significantly associated with osteoporosis (Supplementary Table 2 ).
P4HB is a protein coding gene which encodes the membrane protein beta subunit of prolyl 4-hydroxylase. The major biological function of P4HB is catalyzing the formation/ rearrangement of disulfide bonds; thus, it is involved in homeostatic processes. It can modify proteins' structures both inside and outside the cell and may therefore play important roles in cell adhesion and cell migration [33] . Previous publications indicated that a heterozygous missense mutation in P4HB may cause a severe bone fragility disorder called Cole-Carpenter syndrome [34] . Another previous proteomics study in Chinese premenopausal females identified P4HB as a significant gene related to osteoporosis [35] . Meanwhile, a study on the pathogenesis of osteoporosis demonstrated that PD1 (an alias of P4HB) is downregulated in osteoblasts from osteoporosis patients [36] . In this study, P4HB is differentially expressed between high and low BMD groups with a highly significant p value (p = 0.0021). As the sole source of osteoclast precursors for the adult peripheral skeleton, PBMs can With normalized expression data, Student's t test was applied to identify DEPs. A p value less than 0.05 was set as the nominal cutoff for significance. 36 proteins reached the nominal significant statistical level. The ratio H/L represents the fold change of protein expression level between low and high BMD groups, which reflected that proteins were upregulated (>1) or downregulated (<1) in the high BMD group The first column lists major membrane-related terms from cellular component analysis; the second column lists the number of genes enriched in each specific term; the third column shows the corresponding p value of each term; the last column lists the DEPs enriched in each specific term migrate from the bloodstream to bone and differentiate into osteoclasts which play crucial roles in bone maintenance and homeostasis [6] . All above, we can demonstrate with high confidence that P4HB may be involved in bone metabolism by regulating cell migration and homeostasis. CD36 and ITGB1 are both involved in the ECM-receptor interaction pathway. The extracellular matrix (ECM) plays a significant role in cell behavior and migration during organ or tissue morphogenesis and homeostasis [37] . CD36 is also known as leukocyte differentiation antigen CD36, which may imply a role for CD36 in the process of monocyte differentiation and therefore regulating osteoclastogenesis. CD36 has been identified as a differentially expressed gene, and several gene expression studies have found that it is closely related to osteoporosis [38, 39] . CD36 binding factors may stimulate bone resorption by osteoclasts [40] . CD36 knockout experiments in mouse model revealed that CD36KO mice tend to have low bone mass compare with wild type mouse [41] . ITGB1 is also a key gene in the leukocyte transendothelial migration pathway. ITGB1 encodes the protein integrin, which is required during the proliferation and differentiation of osteoblasts [42] . Bone morphogenetic proteins-2 (BMP2) can regulate the expression level of integrin, and integrin may affect BMP2 function in osteoclasts. Crosstalk between integrin and BMP2 plays a crucial role in osteoclast activity [43] . Consistently, as significant membrane genes identified in our study, CD36 and ITGB1 were differentially expressed between high and low BMD groups. They play central roles in all DEPs and have a close relationship with well-known bone-related pathways. In addition, evidence from the transcriptomic and genomic levels further support the contribution of these two genes to osteoporosis. From the network, we highlighted several significant membrane genes such as CD36, ITGB1, ACTNI, and P4HB as hub genes in this gene set The major biological functions of ACTN1 genes include regulation of actin cytoskeleton and calcium ion binding. Proteins included in the regulation of actin cytoskeleton pathway perform diverse effects on cell activity, including changes in cell shape, migration, proliferation, and survival in many cell types [44] . A previous study showed that osteoclasts undergo internal structural changes including rearrangements of actin cytoskeleton that prepare it to resorb bone [45] . Another study suggested that the status of the actin cytoskeleton signaling network determines the size of osteoclast-like cells during cell fusion [46] . As one of the key driver genes, ACTN1 plays a central role in the Bregulation of actin cytoskeletonp athway. Furthermore, ACTN1 is an important transmembrane protein for calcium ion binding and transportation. Calcium is the basic component of bone matrix [47] . As a regulator of calcium ion binding and transporting, ACTN1 has been associated with osteoporosis in previous publications [39] . In our study, evidence from proteomics data, RNA expression data, and GWAS data support ACTN1 as a potential genetic risk for osteoporosis.
Altogether, in our study, label-free based quantitative subcellular proteomics integrated with network analysis highlighted several candidate genes including P4HB, ITGB1, CD36, and ACTN1 that may be involved in osteoporosis. All of them are predicted as significant membrane proteins with high confidence and enriched in bone-related biological process. Since Fisher's meta-analysis is a little bit liberal and may have potential limitation, combined p value from meta-analysis for the above four genes should be treated with caution (the last two columns in Supplementary Table 2 ). However, all of them are validated in at least one individual dataset from single omics level. 
Conclusions
In our study, label-free based quantitative subcellular proteomics integrated with network analysis highlighted several candidate genes including P4HB, ITGB1, CD36, and ACTN1 that may be involved in osteoporosis. All of them are predicted as significant membrane proteins with high confidence and enriched in bone-related biological process. The results were further verified in transcriptomic and genomic levels.
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